{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:17:23Z","timestamp":1785845843600,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["200500004"],"award-info":[{"award-number":["200500004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KUN2015-7626"],"award-info":[{"award-number":["KUN2015-7626"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017246","name":"Radboud Institute for Health Sciences","doi-asserted-by":"crossref","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100017246","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Risk-based breast cancer screening may improve the benefit-harm ratio of screening by tailoring policy to a woman\u2019s personal breast cancer risk. This study aims to explore Dutch women\u2019s preferences regarding the organisation and implementation of a risk-based breast cancer screening and prevention programme, identifying potential barriers and facilitators to uptake.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 5110 participants in the Dutch Personalised RISk-based MAmmography screening (PRISMA) study were invited, of whom 942 completed a two-part web-based survey. The first part contained questions about personal characteristics; for the second part, women were randomly assigned to one of four hypothetical breast cancer risk scenarios (i.e. low, average, moderate, or high) with subsequent tailored screening and prevention advice. Descriptive statistics are used to present women\u2019s organisational preferences. Univariable and multivariable logistic regression analyses were performed using seven proxy measures for acceptability of risk-based screening (e.g., interest in risk) and risk-based prevention (e.g., willingness to change diet).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Interest in breast cancer risk was high (80.3%). Higher assigned risk scenario was most consistently associated with acceptance of tailored screening and prevention recommendations. Increased acceptance of lifestyle changes was additionally associated with higher education. Having a first degree family history of breast cancer decreased women\u2019s motivation to participate in preventative lifestyle measures. Acceptability of medication was associated with a woman\u2019s general beliefs about the (over)use and benefit-harm balance of medication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Dutch women generally appear in favour of receiving their breast cancer risk estimate with subsequent tailored screening and prevention recommendations. However, women\u2019s level of acceptance depends on their assigned risk category. Offering tailored screening and prevention recommendations to low-risk women will be most challenging. Educating women on the benefits and harms of all risk-based screening and prevention strategies is key to acceptability and informed decision-making.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-07464-2","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T21:03:04Z","timestamp":1602018184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Dutch women\u2019s intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-5881","authenticated-orcid":false,"given":"Linda","family":"Rainey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"van der Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille J. M.","family":"Broeders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"7464_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086858","volume":"9","author":"E Vilaprinyo","year":"2014","unstructured":"Vilaprinyo E, Forne C, Carles M, Sala M, Pla R, Castells X, et al. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLoS One. 2014;9:e86858.","journal-title":"PLoS One"},{"key":"7464_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/jamaoncol.2017.4881","volume":"4","author":"E Van Veen","year":"2018","unstructured":"Van Veen E, Brentnall AR, Byers H, Harkness EF, Astley SM, Sampson S, et al. Improving classical breast cancer risk prediction with single nucleotide polymorphisms and mammographic density. JAMA Oncol. 2018;4:476\u201382.","journal-title":"JAMA Oncol"},{"key":"7464_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fonc.2012.00045","volume":"2","author":"C Senore","year":"2012","unstructured":"Senore C, Giordano L, Bellisario C, Di Stefano F, Segnan N. Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature. Frontiers Oncol. 2012;2:45.","journal-title":"Frontiers Oncol"},{"key":"7464_CR4","doi-asserted-by":"publisher","DOI":"10.3310\/pgfar04110","volume-title":"An Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study","author":"DG Evans","year":"2016","unstructured":"Evans DG, Astley S, Stavrinos P, Harkeness EF, Donnelly LS, Dawe S, et al. An Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Southampton: NIHR Journals Library; 2016."},{"issue":"1","key":"7464_CR5","first-page":"113","volume":"39","author":"BA Fisher","year":"2016","unstructured":"Fisher BA, Wilkinson L, Valencia A. Women\u2019s interest in a personal breast cancer risk assessment and lifestyle advice at NHS mammography screening. J Public Health. 2016;39(1):113\u201321.","journal-title":"J Public Health"},{"issue":"12","key":"7464_CR6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41416-018-0069-y","volume":"118","author":"DP French","year":"2018","unstructured":"French DP, Southworth J, Howell A, Harvie M, Stavrinos P, Watterson D, et al. Psychological impact of providing women with personalised 10-year breast cancer risk estimates. Br J Cancer. 2018;118(12):1648.","journal-title":"Br J Cancer"},{"issue":"11","key":"7464_CR7","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","volume":"4","author":"N Pashayan","year":"2018","unstructured":"Pashayan N, Morris S, Gilbert FJ, Pharoah P. Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model. JAMA Oncol. 2018;4(11):1504\u201310.","journal-title":"JAMA Oncol"},{"key":"7464_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/pon.5051","volume":"28","author":"L Rainey","year":"2019","unstructured":"Rainey L, Jervaeus A, Donnelly LS, Evans DG, Hammarstr\u00f6m M, Hall P, et al. Women\u2019s perceptions of personalised risk-based breast cancer screening and prevention: an international focus group study. Psycho-oncol. 2019;28:1056\u201362.","journal-title":"Psycho-oncol"},{"issue":"3","key":"7464_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"issue":"5","key":"7464_CR10","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1017\/S0033291702005822","volume":"32","author":"PM Salkovskis","year":"2002","unstructured":"Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32(5):843\u201353.","journal-title":"Psychol Med"},{"issue":"2","key":"7464_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1037\/pas0000332","volume":"29","author":"F te Poel","year":"2017","unstructured":"te Poel F, Hartmann T, Baumgartner SE, Tanis M. A psychometric evaluation of the Dutch short health anxiety inventory in the general population. Psychol Assess. 2017;29(2):186.","journal-title":"Psychol Assess"},{"issue":"2","key":"7464_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/109019817800600107","volume":"6","author":"KA Wallston","year":"1978","unstructured":"Wallston KA, Wallston BS. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monographs. 1978;6(2):160\u201370.","journal-title":"Health Educ Monographs"},{"issue":"5","key":"7464_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/1359105305055304","volume":"10","author":"KA Wallston","year":"2005","unstructured":"Wallston KA. The validity of the multidimensional health locus of control scales. J Health Psychol. 2005;10(5):623\u201331.","journal-title":"J Health Psychol"},{"issue":"2","key":"7464_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-3999(67)90010-4","volume":"11","author":"TH Holmes","year":"1967","unstructured":"Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967;11(2):213\u20138.","journal-title":"J Psychosom Res"},{"issue":"1","key":"7464_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870449908407311","volume":"14","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1\u201324.","journal-title":"Psychol Health"},{"key":"7464_CR16","doi-asserted-by":"publisher","unstructured":"Ghanouni A, Sanderson SC, Pashayan N, Renzi C, von Wagner C, Waller J. Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey. J Med Screen. 2019. https:\/\/doi.org\/10.1177\/0969141319883662.","DOI":"10.1177\/0969141319883662"},{"issue":"3","key":"7464_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.breast.2015.02.001","volume":"24","author":"SF Meisel","year":"2015","unstructured":"Meisel SF, Pashayan N, Rahman B, Side L, Fraser L, Gessler S, et al. Adjusting the frequency of mammography screening on the basis of genetic risk: attitudes among women in the UK. Breast. 2015;24(3):237\u201341.","journal-title":"Breast"},{"key":"7464_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/0284186X.2015.1043024","volume":"55","author":"M Koitsalu","year":"2016","unstructured":"Koitsalu M, Sprangers MA, Eklund M, Czene K, Hall P, Gr\u00f6nberg H, et al. Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer. Acta Oncol. 2016;55:45\u201351.","journal-title":"Acta Oncol"},{"issue":"5","key":"7464_CR19","doi-asserted-by":"publisher","first-page":"644e50","DOI":"10.1016\/j.breast.2014.06.014","volume":"23","author":"IM Collins","year":"2014","unstructured":"Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, et al. Assessing and managing breast cancer risk: clinicians\u2019 current practice and future needs. Breast. 2014;23(5):644e50.","journal-title":"Breast"},{"issue":"3","key":"7464_CR20","doi-asserted-by":"publisher","first-page":"295e306","DOI":"10.2217\/pme.13.20","volume":"10","author":"LA Orlando","year":"2013","unstructured":"Orlando LA, Henrich VC, Hauser ER, Wilson C, Ginsburg GS. Genomedical Connection. The genomic medicine model: an integrated approach to implementation of family health history in primary care. Pers Med. 2013;10(3):295e306.","journal-title":"Pers Med"},{"issue":"5","key":"7464_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1365-2702.2004.01108.x","volume":"14","author":"T McCready","year":"2005","unstructured":"McCready T, Littlewood D, Jenkinson J. Breast self-examination and breast awareness: a literature review. J Clin Nurs. 2005;14(5):570\u20138.","journal-title":"J Clin Nurs"},{"issue":"2","key":"7464_CR22","doi-asserted-by":"publisher","first-page":"CD003373","DOI":"10.1002\/14651858.CD003373","volume":"2003","author":"JP K\u00f6sters","year":"2003","unstructured":"K\u00f6sters JP, G\u01fftzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2003;2003(2):CD003373. https:\/\/doi.org\/10.1002\/14651858.CD003373.","journal-title":"Cochrane Database Syst Rev"},{"key":"7464_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1186\/s12885-019-6279-8","volume":"19","author":"M Harvie","year":"2019","unstructured":"Harvie M, Pegington M, French D, Cooper G, McDiarmid S, Howell A, et al. Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials. BMC Cancer. 2019;19:1089.","journal-title":"BMC Cancer"},{"key":"7464_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/annonc\/mdv590","volume":"27","author":"SG Smith","year":"2016","unstructured":"Smith SG, Sestak I, Forster A, Partridge A, Side L, Wolf MS, et al. Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol. 2016;27:575\u201390.","journal-title":"Ann Oncol"},{"issue":"5","key":"7464_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr3233","volume":"14","author":"M Lazzeroni","year":"2012","unstructured":"Lazzeroni M, Serrano D, Dunn BK, Heckman-Stoddard BM, Lee O, Khan S, et al. Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug. Breast Cancer Res. 2012;14(5):214.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"7464_CR26","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1080\/0284186X.2018.1481291","volume":"57","author":"L Rainey","year":"2018","unstructured":"Rainey L, van der Waal D, Wengstr\u00f6m Y, Jervaeus A, Broeders MJM. Women\u2019s perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review. Acta Oncol. 2018;57(10):1275\u201383.","journal-title":"Acta Oncol"},{"issue":"7","key":"7464_CR27","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/ijc.29912","volume":"138","author":"TM Ripping","year":"2016","unstructured":"Ripping TM, Hubbard RA, Otten JD, den Heeten GJ, Verbeek ALM, Broeders MJM. Towards personalized screening: cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer. Int J Cancer. 2016;138(7):1619\u201325.","journal-title":"Int J Cancer"},{"key":"7464_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2017.03.014","volume":"78","author":"A van Erkelens","year":"2017","unstructured":"van Erkelens A, Sie AS, Manders P, Visser A, Duijm LE, Mann RM, et al. Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress. Eur J Cancer. 2017;78:45\u201352.","journal-title":"Eur J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07464-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07464-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:35:50Z","timestamp":1633502150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07464-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7464"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07464-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was acquired from the regional ethics committee CMO Arnhem-Nijmegen, the Netherlands (2015\u20131773). Written informed consent was obtained from all participants prior to the start of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"965"}}